News Focus
News Focus
icon url

Couch

11/16/15 4:51 PM

#242925 RE: lemmy #242920

Must be why Bavituximab is getting a little air play as of late via the scientific community.

http://www.targetedonc.com/publications/special-reports/2015/nsclc-issue9/immunotherapy-becoming-mainstay-of-nsclc-therapy
icon url

jimsgtx

11/16/15 5:23 PM

#242926 RE: lemmy #242920

Like I said Lem... Stick around for another year... Imho, buy now... Pphm will be a 4-6 billion company by then.